Evidence map›Paper›PMID 30185233›Full record

ArticleMicrobiome2018

High-resolution ISR amplicon sequencing reveals personalized oral microbiome.

Chiranjit Mukherjee, Clifford J Beall, Ann L Griffen, Eugene J Leys

Erratum issuedAbstract readEvaluation Study
In one paragraph

Article in Microbiome, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Infection and the microbiome in bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  7. Article
  8. Article
  9. Explore variation of salivary bacteria across time and geolocations.International journal of legal medicine · 2024
    Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Chiranjit MukherjeeCollege of Dentistry, The Ohio State University, Columbus, OH, USA.
Clifford J BeallCollege of Dentistry, The Ohio State University, Columbus, OH, USA.
Ann L GriffenCollege of Dentistry, The Ohio State University, Columbus, OH, USA. griffen.1@osu.edu.
Eugene J LeysCollege of Dentistry, The Ohio State University, Columbus, OH, USA.

Funding

Culturing of the uncultured: reverse genomics and multispecies consortia in oralR01DE024463 · NIDCR · UT-BATTELLE, LLC-OAK RIDGE NATIONAL LAB · PI JOULINE, IGOR B., LEYS, EUGENE J · 2014 to 2018
$8.2M
Acquisition of the Human Oral MicrobiomeR01DE024327 · NIDCR · OHIO STATE UNIVERSITY · PI GRIFFEN, ANN L, LEYS, EUGENE J · 2014 to 2018
$1.9M
NIDCR NIH HHS R01 DE024327NIDCR NIH HHS R01 DE024463
6 · The paper itself

Abstract

backgroundSequencing of the 16S rRNA gene has been the standard for studying the composition of microbial communities. While it allows identification of bacteria at the level of species, this method does not usually provide sufficient information to resolve communities at the sub-species level. Species-level resolution is not adequate for studies of transmission or stability or for exploring subspecies variation in disease association. Strain level analysis using whole metagenome shotgun sequencing has significant limitations that can make it unsuitable for large-scale studies. Achieving sufficient depth of sequencing can be cost-prohibitive, and even with adequate coverage, deconvoluting complex communities such as the oral microbiota is computationally very challenging. Thus, there is a need for high-resolution, yet cost-effective, high-throughput methods for characterizing microbial communities.

resultsSignificant improvement in resolution for amplicon-based bacterial community analysis was achieved by combining amplicon sequencing of a high-diversity marker gene, the ribosomal 16-23S intergenic spacer region (ISR), with a probabilistic error modeling based denoising algorithm, DADA2. The resolving power of this new approach was compared to that of both standard and high-resolution 16S-based approaches using a set of longitudinal subgingival plaque samples. The ISR strategy resulted in a 5.2-fold increase in community resolution compared to reference-based 16S rRNA gene analysis and showed 100% accuracy in predicting the correct source of a clinical sample. Individuals' microbial communities were highly personalized, and although they exhibited some drift in membership and levels over time, that difference was always smaller than the differences between any two subjects, even after 1 year. The construction of an ISR database from publicly available genomic sequences allowed us to explore genomic variation within species, resulting in the identification of multiple variants of the ISR for most species.

conclusionsThe ISR approach resulted in significantly improved resolution of communities and revealed a highly personalized human oral microbiota that was stable over 1 year. Multiple ISR types were observed for all species examined, demonstrating a high level of subspecies variation in the oral microbiota. The approach is high-throughput, high-resolution yet cost-effective, allowing subspecies-level community fingerprinting at a cost comparable to that of 16S rRNA gene amplicon sequencing. It will be useful for a range of applications that require high-resolution identification of organisms, including microbial tracking, community fingerprinting, and potentially for identification of virulence-associated strains.

Indexed as

MicrobiotaAdultBacteriaDNA, BacterialDNA, IntergenicFemaleGenetic VariationHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMouthPhylogenyRNA, Ribosomal, 16SYoung AdultDNA, BacterialDNA, IntergenicRNA, Ribosomal, 16S16S rRNA gene sequencingHigh-resolution ISR sequencingLongitudinal studyOral microbiomePersonalized microbiomeSub-species resolution

Identifiers

PMID30185233
PMCPMC6126016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.